AbCellera Biologics Inc. (ABCL)

NASDAQ: ABCL · Real-Time Price · USD

3.610

+0.020 (0.56%)

At close: Feb 27, 2026, 4:00 PM EST

3.700

+0.090 (2.50%)

After-hours: Feb 27, 2026, 7:59 PM EST

AbCellera Biologics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-146.41	-162.86	-146.4	158.52	153.46
Depreciation & Amortization	28.82	65	30.89	24.7	17.25
Asset Writedown & Restructuring Costs	-	32	-	8.4	-
Stock-Based Compensation	55.79	67.58	64.18	49.48	30.65
Other Operating Activities	1.2	-84.44	-5.78	6.43	1.55
Change in Accounts Receivable	-55.62	-75.12	-45.93	106.46	22.48
Change in Accounts Payable	3.46	10.64	-15.1	-2.09	-3.24
Change in Unearned Revenue	-5.83	26.04	25.55	15.45	39.34
Change in Income Taxes	-29.84	6.65	30.46	-88.61	-13.53
Change in Other Net Operating Assets	17.15	5.95	18.25	-1.38	-3.38
Operating Cash Flow	-131.3	-108.56	-43.88	277.36	244.58
Operating Cash Flow Growth	-	-	-	13.40%	977.94%
Capital Expenditures	-42.77	-78.4	-76.95	-70.66	-58.45
Cash Acquisitions	-	-	-	-	-11.46
Sale (Purchase) of Intangibles	-	-	-	-2	-
Investment in Securities	75.91	164.1	-169.47	-296.4	-294.96
Other Investing Activities	54.61	35.71	25.31	16.43	32.62
Investing Cash Flow	87.75	121.41	-221.11	-352.63	-332.25
Long-Term Debt Issued	29.73	13.5	11.59	2.76	5.49
Total Debt Issued	29.73	13.5	11.59	2.76	5.49
Net Debt Issued (Repaid)	29.73	13.5	11.59	2.76	5.49
Other Financing Activities	-15.65	-0.73	-1.23	-4.38	-9.37
Financing Cash Flow	14.08	12.77	10.36	-1.63	-3.89
Foreign Exchange Rate Adjustments	1.1	-2.62	0.59	-9.6	-1.43
Net Cash Flow	-28.37	23.01	-254.04	-86.49	-92.97
Free Cash Flow	-174.07	-186.95	-120.82	206.7	186.13
Free Cash Flow Growth	-	-	-	11.05%	1329.91%
Free Cash Flow Margin	-231.69%	-648.40%	-317.75%	42.58%	49.61%
Free Cash Flow Per Share	-0.58	-0.64	-0.42	0.66	0.58
Levered Free Cash Flow	-176	-177.77	-102.4	205.62	143.8
Unlevered Free Cash Flow	-176	-177.77	-102.4	205.62	143.8
Change in Working Capital	-70.69	-25.84	13.23	29.83	41.67

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q